{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:20:31Z","timestamp":1792488031411,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07079-w","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:25:01Z","timestamp":1759407901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cathepsin K: a novel association with glucose intolerance, insulin resistance, and subclinical atherosclerosis in T2DM"],"prefix":"10.1186","volume":"23","author":[{"given":"Carolina","family":"Averta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Massimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Coppolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Bolignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velia","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Palummo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Perticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6341-4572","authenticated-orcid":false,"given":"Gaia Chiara","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"6","key":"7079_CR1","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/HYPERTENSIONAHA.111.180935","volume":"58","author":"XW Cheng","year":"2011","unstructured":"Cheng XW, Huang Z, Kuzuya M, Okumura K, Murohara T. Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. Hypertension. 2011;58(6):978\u201386.","journal-title":"Hypertension"},{"issue":"9","key":"7079_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.31083\/j.rcm2309311","volume":"23","author":"D Bolignano","year":"2022","unstructured":"Bolignano D, Greco M, Arcidiacono V, Presta P, Caglioti A, Russo E, et al. Decreased cathepsin-K mirrors the severity of subclinical atherosclerosis in kidney transplant recipients. Rev Cardiovasc Med. 2022;23(9):311.","journal-title":"Rev Cardiovasc Med"},{"key":"7079_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12967-016-0907-8","volume":"14","author":"A Petrera","year":"2016","unstructured":"Petrera A, Gassenhuber J, Ruf S, Gunasekaran D, Esser J, Shahinian JH, et al. Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels. J Transl Med. 2016;14:153.","journal-title":"J Transl Med"},{"issue":"2","key":"7079_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2337\/db12-0350","volume":"62","author":"Y Hua","year":"2013","unstructured":"Hua Y, Zhang Y, Dolence J, Shi GP, Ren J, Nair S. Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction. Diabetes. 2013;62(2):498\u2013509.","journal-title":"Diabetes"},{"issue":"1\u20132","key":"7079_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11010-016-2924-6","volume":"428","author":"S Mehra","year":"2017","unstructured":"Mehra S, Kumar M, Manchanda M, Singh R, Thakur B, Rani N, et al. Clinical significance of cathepsin L and cathepsin B in dilated cardiomyopathy. Mol Cell Biochem. 2017;428(1\u20132):139\u201347.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"7079_CR6","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1159\/000494656","volume":"50","author":"D Lian","year":"2018","unstructured":"Lian D, Lai J, Wu Y, Wang L, Chen Y, Zhang Y, et al. Cathepsin B-mediated NLRP3 inflammasome formation and activation in Angiotensin II -induced hypertensive mice: role of macrophage digestion dysfunction. Cell Physiol Biochem. 2018;50(4):1585\u2013600.","journal-title":"Cell Physiol Biochem"},{"issue":"12","key":"7079_CR7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.111.066712","volume":"125","author":"XW Cheng","year":"2012","unstructured":"Cheng XW, Shi GP, Kuzuya M, Sasaki T, Okumura K, Murohara T. Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication. Circulation. 2012;125(12):1551\u201362.","journal-title":"Circulation"},{"key":"7079_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0076-6879(81)80043-2","volume":"80","author":"AJ Barrett","year":"1981","unstructured":"Barrett AJ, Kirschke H. Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol. 1981;80:535\u201361.","journal-title":"Methods Enzymol"},{"issue":"9","key":"7079_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1357-4310(99)01563-4","volume":"5","author":"F Lazner","year":"1999","unstructured":"Lazner F, Gowen M, Kola I. An animal model for pycnodysostosis: the role of cathepsin K in bone remodelling. Mol Med Today. 1999;5(9):413\u20134.","journal-title":"Mol Med Today"},{"issue":"6","key":"7079_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1084\/jem.192.6.789","volume":"192","author":"A Punturieri","year":"2000","unstructured":"Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, et al. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med. 2000;192(6):789\u201399.","journal-title":"J Exp Med"},{"issue":"9","key":"7079_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1515\/hsz-2013-0134","volume":"394","author":"M Novinec","year":"2013","unstructured":"Novinec M, Lenar\u010di\u010d B. Cathepsin k: a unique collagenolytic cysteine peptidase. Biol Chem. 2013;394(9):1163\u201379.","journal-title":"Biol Chem"},{"issue":"5","key":"7079_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/MOL.0000000000000111","volume":"25","author":"AC Newby","year":"2014","unstructured":"Newby AC. Proteinases and plaque rupture: unblocking the road to translation. Curr Opin Lipidol. 2014;25(5):358\u201366.","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"7079_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1161\/CIRCULATIONAHA.110.970038","volume":"123","author":"YS Chatzizisis","year":"2011","unstructured":"Chatzizisis YS, Baker AB, Sukhova GK, Koskinas KC, Papafaklis MI, Beigel R, et al. Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress colocalize with coronary atheromata with thin fibrous caps in pigs. Circulation. 2011;123(6):621\u201330.","journal-title":"Circulation"},{"issue":"4","key":"7079_CR14","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.3892\/etm.2017.4935","volume":"14","author":"H Zhao","year":"2017","unstructured":"Zhao H, Qin X, Wang S, Sun X, Dong B. Decreased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability. Exp Ther Med. 2017;14(4):3471\u20136.","journal-title":"Exp Ther Med"},{"issue":"3","key":"7079_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1172\/JCI181","volume":"102","author":"GK Sukhova","year":"1998","unstructured":"Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest. 1998;102(3):576\u201383.","journal-title":"J Clin Invest"},{"issue":"17","key":"7079_CR16","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIRCULATIONAHA.106.660340","volume":"115","author":"FA Jaffer","year":"2007","unstructured":"Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pande AN, et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation. 2007;115(17):2292\u20138.","journal-title":"Circulation"},{"issue":"8","key":"7079_CR17","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1097\/HJH.0000000000002424","volume":"38","author":"X Meng","year":"2020","unstructured":"Meng X, Piao L, Wang H, Inoue A, Huang Z, Jiang H, et al. Deficiency of cysteinyl cathepsin K suppresses the development of experimental intimal hyperplasia in response to chronic stress. J Hypertens. 2020;38(8):1514\u201324.","journal-title":"J Hypertens"},{"issue":"1","key":"7079_CR18","doi-asserted-by":"publisher","first-page":"8703","DOI":"10.1038\/s41598-017-09037-z","volume":"7","author":"R Guo","year":"2017","unstructured":"Guo R, Hua Y, Rogers O, Brown TE, Ren J, Nair S. Cathepsin K knockout protects against cardiac dysfunction in diabetic mice. Sci Rep. 2017;7(1):8703.","journal-title":"Sci Rep"},{"issue":"4","key":"7079_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1507\/endocrj.EJ14-0336","volume":"62","author":"J Han","year":"2015","unstructured":"Han J, Wei L, Xu W, Lu J, Wang C, Bao Y, et al. CTSK inhibitor exert its anti-obesity effects through regulating adipocyte differentiation in high-fat diet induced obese mice. Endocr J. 2015;62(4):309\u201317.","journal-title":"Endocr J"},{"issue":"1","key":"7079_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2013.01.004","volume":"228","author":"XW Cheng","year":"2013","unstructured":"Cheng XW, Kikuchi R, Ishii H, Yoshikawa D, Hu L, Takahashi R, et al. Circulating cathepsin K as a potential novel biomarker of coronary artery disease. Atherosclerosis. 2013;228(1):211\u20136.","journal-title":"Atherosclerosis"},{"issue":"1","key":"7079_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00380-014-0570-z","volume":"31","author":"Y Izumi","year":"2016","unstructured":"Izumi Y, Hayashi M, Morimoto R, Cheng XW, Wu H, Ishii H, et al. Impact of circulating cathepsin k on the coronary calcification and the clinical outcome in chronic kidney disease patients. Heart Vessels. 2016;31(1):6\u201314.","journal-title":"Heart Vessels"},{"issue":"7","key":"7079_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/dmrr.724","volume":"23","author":"F Andreozzi","year":"2007","unstructured":"Andreozzi F, Succurro E, Mancuso MR, Perticone M, Sciacqua A, Perticone F, et al. Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg\/dL threshold. Diabetes Metab Res Rev. 2007;23(7):547\u201350.","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"7079_CR23","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.2337\/dc07-0419","volume":"30","author":"MA Marini","year":"2007","unstructured":"Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care. 2007;30(8):2145\u20137.","journal-title":"Diabetes Care"},{"key":"7079_CR24","doi-asserted-by":"crossref","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62\u20139.","DOI":"10.2337\/dc10-S062"},{"issue":"5","key":"7079_CR25","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2337\/dc11-2032","volume":"35","author":"MA Marini","year":"2012","unstructured":"Marini MA, Succurro E, Castaldo E, Cufone S, Arturi F, Sciacqua A, et al. Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. Diabetes Care maggio. 2012;35(5):1144\u20139.","journal-title":"Diabetes Care maggio"},{"issue":"6","key":"7079_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","volume":"57","author":"RB Devereux","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450\u20138.","journal-title":"Am J Cardiol"},{"issue":"7","key":"7079_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"10","key":"7079_CR28","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953\u20132041.","journal-title":"J Hypertens"},{"key":"7079_CR29","doi-asserted-by":"crossref","unstructured":"Lutgens E, Lutgens SP, Faber BC, Heeneman S, Gijbels MM, De Winther MP et al. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation. 2006;113(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/16365196\/","DOI":"10.1161\/CIRCULATIONAHA.105.561449"},{"key":"7079_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00433","volume":"8","author":"R Dai","year":"2020","unstructured":"Dai R, Wu Z, Chu HY, Lu J, Lyu A, Liu J, et al. Cathepsin K: the action in and beyond bone. Front Cell Dev Biol. 2020;8:433.","journal-title":"Front Cell Dev Biol"},{"key":"7079_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00122","volume":"11","author":"C Cipriani","year":"2020","unstructured":"Cipriani C, Colangelo L, Santori R, Renella M, Mastrantonio M, Minisola S, et al. The interplay between bone and glucose metabolism. Front Endocrinol. 2020;11:122.","journal-title":"Front Endocrinol"},{"key":"7079_CR32","doi-asserted-by":"crossref","unstructured":"Ward H, Jawad AS. Musculoskeletal manifestations of diabetes mellitus\u2014an update. Clin Med. 2025;100498.","DOI":"10.1016\/j.clinme.2025.100498"},{"issue":"1","key":"7079_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.105.561449","volume":"113","author":"E Lutgens","year":"2006","unstructured":"Lutgens E, Lutgens SPM, Faber BCG, Heeneman S, Gijbels MMJ, de Winther MPJ, et al. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation. 2006;113(1):98\u2013107.","journal-title":"Circulation"},{"issue":"2","key":"7079_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jcp.10253","volume":"195","author":"C Chiellini","year":"2003","unstructured":"Chiellini C, Costa M, Novelli SE, Amri EZ, Benzi L, Bertacca A, et al. Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. J Cell Physiol. 2003;195(2):309\u201321.","journal-title":"J Cell Physiol"},{"key":"7079_CR35","doi-asserted-by":"crossref","unstructured":"Xiao Y, Junfeng H, Tianhong L, Lu W, Shulin C, Yu Z et al. Cathepsin K in adipocyte differentiation and its potential role in the pathogenesis of obesity. J. Clin. Endocrinol. Metab.. 2006;91(11). https:\/\/pubmed.ncbi.nlm.nih.gov\/16912123\/","DOI":"10.1210\/jc.2005-2486"},{"key":"7079_CR36","doi-asserted-by":"crossref","unstructured":"Funicello M, Novelli M, Ragni M, Vottari T, Cocuzza C, Soriano-Lopez J, et al. Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores. PloS One. 2007;2(8). https:\/\/pubmed.ncbi.nlm.nih.gov\/17668061\/","DOI":"10.1371\/journal.pone.0000683"},{"issue":"12","key":"7079_CR37","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1161\/ATVBAHA.108.172320","volume":"28","author":"M Yang","year":"2008","unstructured":"Yang M, Sun J, Zhang T, Liu J, Zhang J, Shi MA, et al. Deficiency and inhibition of cathepsin k reduce body weight gain and increase glucose metabolism in mice. Arterioscler Thromb Vasc Biol. 2008;28(12):2202\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7079_CR38","doi-asserted-by":"crossref","unstructured":"Yang M, Sun J, Zhang T, Liu J, Zhang J, Shi MA, et al. Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arterioscler Thromb Vasc Biol. 2008;28(12). https:\/\/pubmed.ncbi.nlm.nih.gov\/18818416\/","DOI":"10.1161\/ATVBAHA.108.172320"},{"issue":"3","key":"7079_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S2213-8587(20)30431-9","volume":"9","author":"J Pearson-Stuttard","year":"2021","unstructured":"Pearson-Stuttard J, Bennett J, Cheng YJ, Vamos EP, Cross AJ, Ezzati M, et al. Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol. 2021;9(3):165\u201373.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"15","key":"7079_CR40","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Eliasson B, Svensson AM, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407\u201318.","journal-title":"N Engl J Med"},{"issue":"3","key":"7079_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/archinternmed.2009.516","volume":"170","author":"SL Sheridan","year":"2010","unstructured":"Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE, et al. The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med. 2010;170(3):230\u20139.","journal-title":"Arch Intern Med"},{"key":"7079_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1472-6963-12-20","volume":"12","author":"B Shillinglaw","year":"2012","unstructured":"Shillinglaw B, Viera AJ, Edwards T, Simpson R, Sheridan SL. Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians. BMC Health Serv Res. 2012;12:20.","journal-title":"BMC Health Serv Res"},{"key":"7079_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1472-6963-8-60","volume":"8","author":"SL Sheridan","year":"2008","unstructured":"Sheridan SL, Crespo E. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Serv Res. 2008;8:60.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"7079_CR44","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrrheum.2011.77","volume":"7","author":"AG Costa","year":"2011","unstructured":"Costa AG, Cusano NE, Silva BC, Cremers S, Bilezikian JP. Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis. Nat Rev Rheumatol. 2011;7(8):447\u201356.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"7079_CR45","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1517\/13543780902832661","volume":"18","author":"D Br\u00f6mme","year":"2009","unstructured":"Br\u00f6mme D, Lecaille F. Cathepsin K inhibitors for osteoporosis and potential off-target effects. Expert Opin Investig Drugs. 2009;18(5):585\u2013600.","journal-title":"Expert Opin Investig Drugs"},{"issue":"7","key":"7079_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrd.2016.132","volume":"15","author":"K Garber","year":"2016","unstructured":"Garber K. Two pioneering osteoporosis drugs finally approach approval. Nat Rev Drug Discov. 2016;15(7):445\u20136.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"7079_CR47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1210\/er.2015-1114","volume":"38","author":"MT Drake","year":"2017","unstructured":"Drake MT, Clarke BL, Oursler MJ, Khosla S. Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned. Endocr Rev. 2017;38(4):325\u201350.","journal-title":"Endocr Rev"},{"issue":"12","key":"7079_CR48","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S2213-8587(19)30346-8","volume":"7","author":"MR McClung","year":"2019","unstructured":"McClung MR, O\u2019Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, et al. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. Lancet Diabetes Endocrinol. 2019;7(12):899\u2013911.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7079_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yjmcc.2018.11.010","volume":"127","author":"W Fang","year":"2019","unstructured":"Fang W, He A, Xiang MX, Lin Y, Wang Y, Li J, et al. Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction. J Mol Cell Cardiol. 2019;127:44\u201356.","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"7079_CR50","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41569-018-0002-3","volume":"15","author":"CL Liu","year":"2018","unstructured":"Liu CL, Guo J, Zhang X, Sukhova GK, Libby P, Shi GP. Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials. Nat Rev Cardiol. 2018;15(6):351\u201370.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"7079_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40620-020-00801-5","volume":"34","author":"D Bolignano","year":"2021","unstructured":"Bolignano D, Greco M, Arcidiacono V, Tripolino O, Vita C, Provenzano M, et al. Increased circulating cathepsin-K levels reflect PTH control in chronic hemodialysis patients. J Nephrol. 2021;34(2):451\u20138.","journal-title":"J Nephrol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07079-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07079-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07079-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T14:04:17Z","timestamp":1759413857000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07079-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7079"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07079-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local Ethics Committee of the University Magna Graecia of Catanzaro (approval code: 2012.63) and written informed consent was obtained from each subject before commencing the studies, in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1046"}}